Proteomics

Dataset Information

0

O-GlcNAcome of OGA stalk domain mutants


ABSTRACT: THe O-GlcNAcome of OGA stlka domain mutation R586A and cancer derived mutation S652F in T-REx HEK293 cells

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Kidney Cell

DISEASE(S): Disease Free

SUBMITTER: Chia-Wei Hu  

LAB HEAD: Jiaoyang Jiang

PROVIDER: PXD039798 | Pride | 2025-01-22

REPOSITORIES: pride

Dataset's files

Source:
Action DRS
2018_05_03_OGAg1_F1_R1.raw Raw
2018_05_03_OGAg1_F1_R2.raw Raw
2018_05_03_OGAg1_F2_R1.raw Raw
2018_05_03_OGAg1_F2_R2.raw Raw
2018_05_03_OGAg1_F3_R1.raw Raw
Items per page:
1 - 5 of 37
altmetric image

Publications

OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy.

Hu Chia-Wei CW   Wang Ao A   Fan Dacheng D   Worth Matthew M   Chen Zhengwei Z   Huang Junfeng J   Xie Jinshan J   Macdonald John J   Li Lingjun L   Jiang Jiaoyang J  

Proceedings of the National Academy of Sciences of the United States of America 20240605 24


O-GlcNAcase (OGA) is the only human enzyme that catalyzes the hydrolysis (deglycosylation) of O-linked beta-<i>N</i>-acetylglucosaminylation (O-GlcNAcylation) from numerous protein substrates. OGA has broad implications in many challenging diseases including cancer. However, its role in cell malignancy remains mostly unclear. Here, we report that a cancer-derived point mutation on the OGA's noncatalytic stalk domain aberrantly modulates OGA interactome and substrate deglycosylation toward a spec  ...[more]

Similar Datasets

2025-01-22 | PXD039800 | Pride
2025-01-22 | PXD039801 | Pride
2016-07-21 | E-GEOD-74846 | biostudies-arrayexpress
2019-09-23 | GSE116620 | GEO
2016-07-21 | GSE74846 | GEO
2024-03-26 | GSE228357 | GEO
2024-08-31 | E-MTAB-14311 | biostudies-arrayexpress
2017-03-14 | PXD005039 | Pride
2024-08-31 | E-MTAB-14350 | biostudies-arrayexpress
2024-10-31 | GSE158746 | GEO